TY - JOUR
T1 - Polychlorinated Biphenyls (PCBs) as Inducers of the Hepatic Microsomal Drug-Metabolizing Enzymes - Effects of Structure on Activity
AU - Safe, S.
AU - Robertson, L.
AU - Safe, L.
AU - Parkinson, A.
AU - Campbell, M. A.
AU - Sawyer, T.
AU - Bandiera, S.
N1 - Funding Information:
The financial assistance of Health and Welfare Canada, Research Programs Directorate, the Natural Sciences and Engineering Research Council, the National Institutes of Health (1-R01-ES02798-01) and the Texas Agricultural Experiment Station, No. 6376, is gratefully appreciated.
PY - 1981/3
Y1 - 1981/3
N2 - The effects of structure on the activity of polychlorinated biphenyls (PCBs) as inducers of hepatic drug-metabolizing enzymes was evaluated by comparing their modes of induction to the classical inducers, phenobarbitone (PB), 3-methylcholanthrene (MC) and PB plus MC (coadmin-istered). Due to the structurally different PCB congeners which induce PB-type activity, it was not possible to accurately define structure-activity rules. It was noted that PCBs which possess 2,4-dichloro-,2,3,4-trichloro-and 2,4,5-trichloro-substitution patterns on both phenyl rings were the most potent PC-type inducers. PCBs which induce MC-type (or aryl hydrocarbon hydroxylase, AHH) activity must be substituted at both para positions and at two or more meta positions (but not necessarily on the same phenyl ring). The compounds defined by these rules, namely, 3,3ʹ, 4,4ʹ-tetra-3,4,4ʹ5-tetra-, 3,3ʹ,4,4ʹ,5-penta- and 3,3ʹ,4,4ʹ,5,5ʹ,-hexachlorobiphenyl induce AHH activity in the rat and in rat hepatoma 4-H-II-E cells in culture and also bind to the cytosolic Ah receptor protein. Substitution of the four MC-type inducers with one ortho-chloro group yields a series of mixed-type inducers which also induce AHH activity and competitively displace 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) from the Ah receptor protein. The di-ortho substituted analogs of 3,3ʹ,4,4ʹ,-tetra-, 3,4,4ʹ,5-tetra, 3,3ʹ,4,4ʹ,5-penta- and 3,3ʹ,4,4ʹ,5,5ʹ-hexachlorobiphenyl have also been tested in the rat and only five congeners, 2,3,4,4ʹ,5-penta-, 2,2ʹ,3,3ʹ4,4ʹ-hexa-, 2,2ʹ,3,4,4ʹ,5ʹ,-hexa-, 2,3,4,4ʹ,5,6-hexa- and 2,2ʹ,3,3ʹ,4,4ʹ,5-heptachlorbiphenyl induced AHH activity at relatively high dose levels. The results are consistent with the proposed mechanism of enzyme induction by 2,3,7,8-TCDD and related halogenated aromatics.
AB - The effects of structure on the activity of polychlorinated biphenyls (PCBs) as inducers of hepatic drug-metabolizing enzymes was evaluated by comparing their modes of induction to the classical inducers, phenobarbitone (PB), 3-methylcholanthrene (MC) and PB plus MC (coadmin-istered). Due to the structurally different PCB congeners which induce PB-type activity, it was not possible to accurately define structure-activity rules. It was noted that PCBs which possess 2,4-dichloro-,2,3,4-trichloro-and 2,4,5-trichloro-substitution patterns on both phenyl rings were the most potent PC-type inducers. PCBs which induce MC-type (or aryl hydrocarbon hydroxylase, AHH) activity must be substituted at both para positions and at two or more meta positions (but not necessarily on the same phenyl ring). The compounds defined by these rules, namely, 3,3ʹ, 4,4ʹ-tetra-3,4,4ʹ5-tetra-, 3,3ʹ,4,4ʹ,5-penta- and 3,3ʹ,4,4ʹ,5,5ʹ,-hexachlorobiphenyl induce AHH activity in the rat and in rat hepatoma 4-H-II-E cells in culture and also bind to the cytosolic Ah receptor protein. Substitution of the four MC-type inducers with one ortho-chloro group yields a series of mixed-type inducers which also induce AHH activity and competitively displace 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) from the Ah receptor protein. The di-ortho substituted analogs of 3,3ʹ,4,4ʹ,-tetra-, 3,4,4ʹ,5-tetra, 3,3ʹ,4,4ʹ,5-penta- and 3,3ʹ,4,4ʹ,5,5ʹ-hexachlorobiphenyl have also been tested in the rat and only five congeners, 2,3,4,4ʹ,5-penta-, 2,2ʹ,3,3ʹ4,4ʹ-hexa-, 2,2ʹ,3,4,4ʹ,5ʹ,-hexa-, 2,3,4,4ʹ,5,6-hexa- and 2,2ʹ,3,3ʹ,4,4ʹ,5-heptachlorbiphenyl induced AHH activity at relatively high dose levels. The results are consistent with the proposed mechanism of enzyme induction by 2,3,7,8-TCDD and related halogenated aromatics.
UR - http://www.scopus.com/inward/record.url?scp=0019760787&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019760787&partnerID=8YFLogxK
U2 - 10.1515/DMDI.1981.3.4.255
DO - 10.1515/DMDI.1981.3.4.255
M3 - Article
AN - SCOPUS:0019760787
SN - 0792-5077
VL - 3
SP - 255
EP - 270
JO - Drug Metabolism and Drug Interactions
JF - Drug Metabolism and Drug Interactions
IS - 4
ER -